Delivery Order SPM20005D1109-JX09
- Not listed
- The federal contract award is for the delivery of a wide range of pharmaceutical products and medical supplies to support the TRICARE North healthcare program, which is managed by the Defense Logistics Agency (DLA) Troop Support Medical. The primary contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $80,582.22 and a completion date of April 20, 2015. The...
- This federal contract award, valued at $83,046.23, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award is for the delivery of various pharmaceutical products and medical supplies to support TRICARE, the healthcare program for U.S. military personnel, veterans, and their families. The $83,355.12 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of May 23, 2016. AmerisourceBergen holds a significant $999,999,999...
- This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $115,686.07, is a Firm Fixed Price Delivery Order to provide a variety of pharmaceutical products and medical supplies to support TRICARE, the healthcare program for U.S. military personnel, veterans, and their families. The contract has no set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, is...
- This federal contract award is a delivery order worth $81,618.68 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the procurement of a variety of medical products and supplies to support TRICARE, the health care program for U.S. military members, retirees, and their families. The contract has a firm fixed price pricing type and does not include any...
- This federal contract award, valued at $212,555.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the delivery of a range of pharmaceutical products and medical supplies to support TRICARE, the healthcare program for active duty and retired military personnel and their families. The contract is a Firm Fixed Price Delivery Order that has a completion date of February 16, 2016. It is not designated as a set-aside contract....
- This federal contract award is for a delivery order with a ceiling value of $82,360.26, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a firm fixed-price arrangement to provide TRICARE North medical supplies. The ultimate completion date is April 2, 2015. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a firm fixed price and is valued at $3,203.52, with a completion date of March 6, 2024. The contract is for the provision of pharmaceutical products and medical supplies in support of TRICARE, the military's healthcare program. Amerisourcebergen Drug Corp is the prime contractor and has...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $75,166.41 firm-fixed-price delivery order contract supports the TRICARE North program, which provides healthcare services to military personnel, retirees, and their families. The contract has an ultimate completion date of April 15, 2015 and was not set aside for any specific business...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $139,088.38 firm-fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA that runs through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes,...
- SPM20005D1109Indefinite Delivery Contract
- SPM20005D1109-JX09Delivery Order
This federal contract award to Amerisourcebergen Drug Corp is for the delivery of a variety of pharmaceutical products and medical supplies to support the TRICARE North military healthcare program. The contract, valued at $97,018.35, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a subdivision of the Department of Defense, and has an ultimate completion date of April 7, 2015. The contract is a Firm Fixed Price delivery order and was not designated with a set-aside requirement. Amerisourcebergen Drug Corp is the prime contractor and holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $97.0k | 4/7/15 |